Replimune
REPL
13.20
-0.05
-0.38%
Replimune
US · REPL
#3130 by market cap
Listed 2018
13.20
-0.05
-0.38%
Live - 5344 symbols - heartbeat 448s ago
· 2026-10-08 08:07
Pre-market
13.28
+0.61%
After-hours
13.20
0.00%
- Market cap
- 1.24B
- P/E (TTM)i
- -4.19
- P/Bi
- 11.78
- EPSi
- -3.38
- Div yieldi
- 0.00%
- 52W posi
- 79%
Reader sentiment
Are you bullish or bearish on REPL?
Anonymous reader poll. Unscientific, not investment advice.
Revenue annual, last 8 years
Key ratios & quality
- Enterprise valuei
- 1.06B
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | -- | -- | -- |
| Gross profit | -- | -- | -- | -- | -- | -- | -- | -- |
| Selling & admin expenses | 8.77M | 17.44M | 23.20M | 38.77M | 50.55M | 59.81M | 72.18M | 98.74M |
| Research & development | 22.17M | 38.76M | 56.75M | 79.55M | 126.53M | 174.96M | 189.45M | 221.18M |
| Operating profit | -28.42M | -53.11M | -77.15M | -115.14M | -174.17M | -232.85M | -259.85M | -318.32M |
| Pretax profit | -30.83M | -52.63M | -80.87M | -118.04M | -174.00M | -215.39M | -246.83M | -314.49M |
| Tax | -- | -- | -- | 0 | 288.00K | 408.00K | 468.00K | -551.00K |
| Net profit | -30.83M | -52.63M | -80.87M | -118.04M | -174.28M | -215.79M | -247.30M | -313.94M |
| Basic EPS | -1 | -2 | -2 | -2 | -3 | -3 | -3 | -3 |
| Diluted EPS | -1.33 | -1.54 | -1.75 | -2.26 | -2.99 | -3.24 | -3.07 | -3.38 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | -- |
| Gross profit | -- | -- | -- | -- | -- | -- |
| Selling & admin expenses | 25.35M | 32.58M | 26.41M | 18.73M | 21.01M | 18.97M |
| Research & development | 53.98M | 57.84M | 57.88M | 53.14M | 52.32M | 49.28M |
| Operating profit | -78.78M | -90.00M | -83.91M | -71.53M | -72.87M | -67.95M |
| Pretax profit | -74.24M | -86.69M | -83.10M | -71.24M | -73.46M | -69.77M |
| Tax | -107.00K | -- | -- | -311.00K | -240.00K | -- |
| Net profit | -74.13M | -86.69M | -83.10M | -70.93M | -73.22M | -69.77M |
| Basic EPS | -1 | -1 | -1 | -1 | -1 | -1 |
| Diluted EPS | -0.82 | -0.95 | -0.90 | -0.77 | -0.76 | -0.72 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 140.98M | 174.25M | 483.75M | 403.98M | 592.60M | 433.67M | 495.88M | 279.12M |
| Cash & ST investments | 134.81M | 168.56M | 476.30M | 395.66M | 583.39M | 420.67M | 483.80M | 268.89M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 154.33M | 234.10M | 543.10M | 461.19M | 646.59M | 487.72M | 551.33M | 332.39M |
| Total current liabilities | 9.89M | 11.87M | 14.55M | 20.76M | 33.83M | 40.44M | 62.36M | 58.23M |
| Short-term debt | -- | 3.28M | 3.46M | 3.63M | 3.76M | 3.88M | 3.98M | 4.04M |
| Long-term debt | -- | 9.80M | -- | -- | 28.65M | 44.81M | 46.38M | 83.31M |
| Total liabilities | 16,470,000.00 | 50,379,000.00 | 44,370,000.00 | 49,963,000.00 | 91,299,000.00 | 113,214,000.00 | 135,485,000.00 | 166,228,000.00 |
| Total equity | 137.86M | 183.72M | 498.73M | 411.23M | 555.29M | 374.51M | 415.84M | 166.16M |
| Retained earnings | -59.77M | -112.30M | -193.17M | -311.20M | -485.49M | -701.28M | -948.58M | -1.26B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 495.88M | 413.37M | 333.75M | 280.35M | 279.12M | 200.81M |
| Cash & ST investments | 483.80M | 403.34M | 323.64M | 269.14M | 268.89M | 195.33M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 551.33M | 469.51M | 389.45M | 333.59M | 332.39M | 252.45M |
| Total current liabilities | 62.36M | 59.56M | 52.90M | 50.09M | 58.23M | 38.41M |
| Short-term debt | 3.98M | 4.04M | 4.05M | 4.08M | 4.04M | 4.04M |
| Long-term debt | 46.38M | 46.79M | 47.21M | 47.63M | 83.31M | 84.11M |
| Total liabilities | 135,485,000.00 | 132,792,000.00 | 126,114,000.00 | 123,051,000.00 | 166,228,000.00 | 146,802,000.00 |
| Total equity | 415.84M | 336.72M | 263.34M | 210.54M | 166.16M | 105.65M |
| Retained earnings | -948.58M | -1.04B | -1.12B | -1.19B | -1.26B | -1.33B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -25.38M | -60.55M | -61.39M | -82.18M | -128.05M | -185.47M | -192.25M | -280.34M |
| Depreciation & amortization | 148.00K | 533.00K | 1.71M | 2.15M | 2.45M | 2.66M | 3.50M | 3.33M |
| Free cash flow | -27.98M | -67.09M | -63.78M | -84.52M | -130.32M | -191.13M | -198.94M | -284.57M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 103.34M | 61.88M | 286.11M | 0 | 187.29M | 0 | 155.73M | 31.15M |
| Ending cash balance | 26.89M | 61.14M | 184.15M | 107.58M | 148.23M | 76.16M | 112.82M | 210.73M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -53.73M | -77.02M | -81.21M | -65.96M | -56.16M | -75.73M |
| Depreciation & amortization | 848.00K | 873.00K | 842.00K | 848.00K | 769.00K | 937.00K |
| Free cash flow | -54.87M | -79.76M | -82.56M | -66.09M | -56.17M | -75.73M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -97.00M | -- | -- | 10.36M | 20.78M | -- |
| Ending cash balance | 112.82M | 99.08M | 104.00M | 124.66M | 210.73M | 187.06M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -56.17 | -32.73 | -23.70 | -25.94 | -36.06 | -46.42 | -62.58 | -107.88 |
| ROA %i | -28.10 | -27.10 | -20.81 | -23.51 | -31.47 | -38.05 | -47.60 | -71.05 |
| ROIC %i | -60.88 | -25.03 | -20.54 | -23.73 | -32.30 | -39.22 | -51.24 | -79.27 |
| 5-year avg ROE %i | -- | -- | -- | -- | -34.92 | -32.97 | -38.94 | -55.78 |
| EBIT margin %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF / sales %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Current ratioi | 14.26 | 14.68 | 33.25 | 19.46 | 17.52 | 10.72 | 7.95 | 4.79 |
| Quick ratioi | 13.89 | 14.44 | 32.95 | 19.21 | 17.33 | 10.52 | 7.82 | 4.65 |
| Debt / assetsi | 0.00 | 17.85 | 6.13 | 7.12 | 9.40 | 15.56 | 13.81 | 33.57 |
| LT debt / equityi | -- | 20.96 | 5.98 | 7.10 | 10.27 | 19.22 | 17.36 | 64.72 |
| Interest coveragei | -- | -26.42 | -25.43 | -52.10 | -40.83 | -31.34 | -30.27 | -34.50 |
| Revenue CAGR (3Y) %i | -- | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -62.58 | -73.44 | -96.24 | -90.88 | -107.88 | -134.29 |
| ROA %i | -47.60 | -55.79 | -69.91 | -67.19 | -71.05 | -82.28 |
| ROIC %i | -51.24 | -59.49 | -75.84 | -72.61 | -79.27 | -91.04 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -- | -- | -- | -- | -- | -- |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 7.95 | 6.94 | 6.31 | 5.60 | 4.79 | 5.23 |
| Quick ratioi | 7.82 | 6.80 | 6.15 | 5.43 | 4.65 | 5.09 |
| Debt / assetsi | 13.81 | 16.26 | 19.60 | 22.89 | 33.57 | 44.36 |
| LT debt / equityi | 17.36 | 21.47 | 27.45 | 34.33 | 64.72 | 102.17 |
| Interest coveragei | -30.27 | -34.28 | -37.89 | -38.57 | -34.50 | -28.91 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Quote time 2026-10-08 08:07:10 · For reference only, not investment advice and not tailored to your situation.